drugset / Trial / NCT07111468

Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis

NCT07111468 ↗

Phase 3 Completed 286 enrolled Yuhan Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

A Multicenter, Randomized, Double-blind, Parallel, Active-controlled, Superiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis

Timeline

Start
2025-08-19
Primary completion
2026-01-15
Completion
2026-01-26

Drugs

EvaluationDrugModalityDoseRoute
Subject YHP2401 Unknown — —
Comparator YHR2402 Unknown — —
Comparator YHR2403 Unknown — —

Indications